In March 2014, Siemens officially presented Unity 3, the latest version of their diagnostic and fitting system for hearing care professionals. Presented at at the American Academy of Audiology's AudiologyNOW! conference in Orlando, Florida, The system combines all of the hearing care professional’s work steps in a single, time-saving process: from computer-assisted hearing ability measurement to the individual fitting of the selected hearing aids.
With acne as the most common skin condition affecting more than 60 million Americans today, it is no surprise that 20 million people have severe enough acne to cause scarring (33 percent of sufferers). Cynosure, the leader in aesthetic lasers, announced today that PicoSure is the first and only picosecond laser now FDA-cleared to treat acne scars.
Oncolab, the Boston-based laboratory which has developed the AMAS cancer test, is making its AACC debut (booth #4051) at this year's conference in Chicago. To date, the test has been run for over 60,000 patients and is emerging as a significant tool in the fight against cancer recurrence.
Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients
Veloxis Pharmaceuticals and Chiesi Farmaceutici today announced that the European Commission has granted marketing authorization for Envarsus® for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.
Boston Scientific Corporation has initiated the full commercial launch of the new POLARIS™ Imaging System. This system will support the Boston Scientific family of intravascular ultrasound (IVUS) catheters, including coronary, peripheral and intra-cardiac echo products. The POLARIS System offers enhanced ease-of-use and more powerful processing capabilities.
SonoSim, Inc., a leading provider of ultrasound education and training, announced today the release of SonoSim LiveScan™, the first ultrasound simulation technology to transform volunteers and standard mannequins into high-fidelity ultrasound training tools.SonoSim uses a combination of advanced motion sensor technology and real-patient ultrasound data to provide medical educators with a true-to-life and cost-effective resource to meet the overwhelming demand to train healthcare providers in bedside ultrasonography.
ViewRay, a privately held medical device company, will be featuring its MRIdian™ system at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM), which will be held July 20-24 in Austin, TX. The MRIdian system – the world's first and only MRI-guided radiation therapy system – is designed to improve the accuracy of cancer treatments through a patented combination of simultaneous Magnetic Resonance Imaging (MRI) and radiation therapy delivery.
Encapsula NanoSciences announces the release of two new liposome based products; Curcusome® and Taurosome™. Curcusome® or liposomal curcumin is a nutraceutical supplement that comes innovatively packaged in a powder release cap for consumer ease. Taurosome™ or liposomal taurine is a human grade cat food additive meant to increase the health and wellness in cats of all ages. Both formulations were recently presented at the 2014 Institute of Food Technologists (IFT) annual meeting as part of the microencapsulation in food applications preparation course, and are now available through the company website: www.encapsula.com.
Zimmer Spine, Inc., a global leader in spine innovation, today announced the U.S. market launch of the Virage OCT Spinal Fixation System, an Occipital-Cervico-Thoracic (OCT) spinal fixation system that will change surgeons' perspective on posterior fixation. The Virage OCT Spinal Fixation System is a posterior system intended for the Occipital-Cervical-Thoracic spine (Occiput-T3). The system consists of a variety of rods, anchors, transverse connectors, screws and polyaxial screws to achieve an implant construct as necessary for the individual case. The system also includes the instruments for inserting and securing the implants.
VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the VIRTUS trial of the VENITI VICI Venous Stent System. The VICI Venous Stent System was designed from inception to be compatible with the unique anatomy and pathophysiology of the venous system. Hundreds of thousands of people around the world suffer from lower-extremity venous disease, and until recently, the only treatment options available involved the use of re-purposed vascular stents originally designed for use in the arterial system.
Breg Inc. have launched the FreeRunnerTM knee brace, designed to help sufferers of Palletofemoral pain return to active lifestyles. FreeRunner's patent-pending design acts on knee anatomy differently than other braces, providing support when patients need it most, and the ability to move normally when they don't. Patellofemoral issues are the most common cause of knee pain seen by health care providers.1 In fact, more than 2.5 million runners are diagnosed with patellofemoral pain syndrome every year.2